Does Microalbuminuria Affect Resistin and Cardiometabolic Risk Factors in Hypertensive Non-Diabetic Females?

• Published in: Haseki Tıp Bülteni
• Main Authors: Sena Ulu, Gül Gürsoy, Berrin Demirbaş, Yaşar Acar, Ahmet Cimbek, Hayriye Cankar Dal, Murat Bayram
• Format: Article
• Language: English
• Published: Haseki Training and Research Hospital 2014-09-01
• Subjects: Albuminuria; hypertension; obesity; c-reactive protein; homocysteine; resistin; blood glucose; lipids
• Online Access: http://www.hasekidergisi.com/article_7272/Does-Microalbuminuria-Affect-Resistin-And-Cardiometabolic-Risk-Factors-In-Hypertensive-Non-diabetic-Females

Aim: Hypertension, obesity, insulin resistance and lipid levels are risk factors for cardiovascular disease. The association of cardiovascular risk with C-reactive protein and homocysteine has been debated for decades. Resistin and microalbuminuria are presumed to be associated with diabetes mellitus, insulin resistance and cardiovascular disease. The objective of our study was to investigate the relationship of microalbuminuria with antropometric and metabolic parameters, C-reactive protein, homocyteine and resistin in non-diabetic hypertensive females. Methods: We conducted a randomized study including 37 female non-diabetic hypertensives without microalbuminuria and 47 female non-diabetic hypertensive patients with microalbuminuria. We made comparisons of anthropometric and metabolic parameters, C-reactive protein, homocysteine, insulin resistance index and resistin between the groups. Results: C-reactive protein, homocysteine, resistin, insulin levels and homeostasis model assessment of insulin resistance were higher in hypertensives with microalbuminuria than in hypertensives without microalbuminuria (all p<0.05). Conclusion: We found that microalbuminuria may have an influence on C-reactive protein, homocysteine and resistin levels in non-diabetic hypertensives. We also think that insulin and insulin resistance may also be related with microalbuminuria in non-diabetic hypertensive female patients. (The Me­di­cal Bul­le­tin of Ha­se­ki 2014; 52: 172-6)